Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jennifer L. Stephens"'
Autor:
Eric D. Anderson, Shelby Fallon, Rafael Meza, Brady McKee, Jennifer L Stephens, Tania Lobo, Michael Ramsaier, Cassandra A. Stanton, Emily Kim, Jinani Jayasekera, Judith Howell, David B. Abrams, Ellen A. Dornelas, Juan C Batlle, George Luta, Danielle E. Deros, Kimberly Davis, Vicky Parikh, Kathryn L. Taylor, Raymond Niaura
Publikováno v:
Contemporary Clinical Trials. 82:25-35
Lung cancer mortality can be reduced by 20% via low dose CT lung cancer screening (LCS) and treatment of early-stage disease. Providing tobacco use treatment to high risk cigarette smokers in the LCS setting may result in health benefits beyond the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::768338276f71d0131af4ec7234c2370f
https://doi.org/10.1016/j.cct.2019.05.006
https://doi.org/10.1016/j.cct.2019.05.006
Autor:
Robert D. Cannon, Paige Roth, David M. Richardson, Marna Rayl Greenberg, David B. Burmeister, Kevin R. Weaver, Pratik M. Parikh, Alexandra M. Amaducci, Andrew W. Sheen, Jennifer L. Stephens, Hanna R. Warren
Publikováno v:
Clinical therapeutics. 42(3)
Purpose We performed an emergency department (ED)–based substance use screening, motivational interview–based intervention, and treatment referral program with the goal of determining sex-specific outcomes. Specifically, in this quality improveme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c7bd3687bb33c6e2809a9a0808f8e0
https://pubmed.ncbi.nlm.nih.gov/32160970
https://pubmed.ncbi.nlm.nih.gov/32160970
Autor:
Shelby Fallon, Jihyoun Jeon, Christopher J Cadham, Jeanne S. Mandelblatt, Jinani Jayasekera, Rafael Meza, Pianpian Cao, David T. Levy, Shailesh Advani, Dejana Braithwaite, Kathryn L. Taylor, Jennifer L Stephens
Publikováno v:
Lung Cancer
OBJECTIVES: Current guidelines recommend delivery of smoking cessation interventions with lung cancer screening (LCS). Unfortunately, there are limited data to guide clinicians and policy-makers in choosing cessation interventions in this setting. Se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6418a5b4e2c6c54ce5150f390c95279
https://europepmc.org/articles/PMC6739236/
https://europepmc.org/articles/PMC6739236/
Publikováno v:
Nature Reviews Microbiology. 5:287-297
Most cells use either a type I or type II synthase to make fatty acids. Trypanosoma brucei, the sleeping sickness parasite, provides the first example of a third mechanism for this process. Trypanosomes use microsomal elongases to synthesize fatty ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63a76c2acda8dcbfb38f4f6f4cf6082
https://doi.org/10.1038/nrmicro1617
https://doi.org/10.1038/nrmicro1617
Publikováno v:
Journal of Biological Chemistry. 282:4427-4436
Whereas other organisms utilize type I or type II synthases to make fatty acids, trypanosomatid parasites such as Trypanosoma brucei are unique in their use of a microsomal elongase pathway (ELO) for de novo fatty acid synthesis (FAS). Because of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f903341c84adb95a097fa8110eed0038
https://doi.org/10.1074/jbc.m609037200
https://doi.org/10.1074/jbc.m609037200
Publikováno v:
Cell. 126:691-699
SummaryAll eukaryotic and prokaryotic organisms are thought to synthesize fatty acids using a type I or type II synthase. In addition, eukaryotes extend pre-existing long chain fatty acids using microsomal elongases (ELOs). We have found that Trypano
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::707cfeb7b1084c298eb9b947a98ab604
https://doi.org/10.1016/j.cell.2006.06.045
https://doi.org/10.1016/j.cell.2006.06.045
Publikováno v:
Annals of Pharmacotherapy. 39:28-31
BACKGROUND: Many patients receiving direct thrombin inhibitor (DTI) therapy require transition to warfarin. This transition may be complicated by DTI-induced elevations in the international normalized ratio (INR). While the effect of argatroban on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7efa58f510f47170c62773079d89fe56
https://doi.org/10.1345/aph.1e126
https://doi.org/10.1345/aph.1e126
Publikováno v:
Annals of Emergency Medicine. 45:417-419
Delayed-onset heparin-induced thrombocytopenia is a syndrome in which thrombocytopenia and thrombosis begin several days after heparin discontinuation. Delayed-onset heparin-induced thrombocytopenia is caused by immunoglobulin G antibodies that are r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9373ca2c6ea8e4249f6836f8d8b6c22e
https://doi.org/10.1016/j.annemergmed.2004.08.005
https://doi.org/10.1016/j.annemergmed.2004.08.005
Publikováno v:
Journal of Hand Therapy. 9:18-26
The purpose of this study was to evaluate the reliability and validity of the Tekdyne hand dynamometer for measuring grip strength as compared with the Jamar dynamometer. Additionally, it was hypothesized that one to six weeks after carpal tunnel rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d669ddc3b04fb9d3614b571e68dbc13
https://doi.org/10.1016/s0894-1130(96)80007-x
https://doi.org/10.1016/s0894-1130(96)80007-x
Publikováno v:
Journal of Hand Therapy. 9:10-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9363c177fda95333f595f532c133602
https://doi.org/10.1016/s0894-1130(96)80006-8
https://doi.org/10.1016/s0894-1130(96)80006-8